- United States
- /
- Medical Equipment
- /
- NasdaqGS:OSUR
Top Penny Stocks To Watch In May 2025
As May 2025 unfolds, the U.S. stock market is experiencing a mix of optimism and caution, with indices like the S&P 500 and Nasdaq poised for their best monthly performance since 2023 amid ongoing trade discussions and economic data surprises. In this climate, penny stocks—often associated with smaller or newer companies—continue to capture investor interest due to their potential for growth at lower price points. Despite being considered a throwback term, these stocks can offer compelling opportunities when backed by strong financials and robust fundamentals.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Rewards & Risks |
| Perfect (NYSE:PERF) | $1.83 | $186.38M | ✅ 3 ⚠️ 0 View Analysis > |
| WM Technology (NasdaqGS:MAPS) | $1.05 | $174.9M | ✅ 4 ⚠️ 1 View Analysis > |
| Puma Biotechnology (NasdaqGS:PBYI) | $3.38 | $167.28M | ✅ 3 ⚠️ 1 View Analysis > |
| Flexible Solutions International (NYSEAM:FSI) | $4.31 | $55.16M | ✅ 1 ⚠️ 2 View Analysis > |
| Imperial Petroleum (NasdaqCM:IMPP) | $2.84 | $98.08M | ✅ 4 ⚠️ 2 View Analysis > |
| Table Trac (OTCPK:TBTC) | $4.77 | $21.99M | ✅ 2 ⚠️ 2 View Analysis > |
| BAB (OTCPK:BABB) | $0.848 | $6.03M | ✅ 2 ⚠️ 3 View Analysis > |
| Lifetime Brands (NasdaqGS:LCUT) | $3.47 | $71.05M | ✅ 3 ⚠️ 2 View Analysis > |
| New Horizon Aircraft (NasdaqCM:HOVR) | $1.10 | $30.73M | ✅ 3 ⚠️ 5 View Analysis > |
| Greenland Technologies Holding (NasdaqCM:GTEC) | $2.02 | $34.79M | ✅ 2 ⚠️ 5 View Analysis > |
Click here to see the full list of 730 stocks from our US Penny Stocks screener.
Let's explore several standout options from the results in the screener.
OraSure Technologies (NasdaqGS:OSUR)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: OraSure Technologies, Inc. is a company that develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices globally with a market cap of $207.20 million.
Operations: OraSure Technologies generates revenue of $161.63 million from its Diagnostics and Molecular Solutions segment.
Market Cap: $207.2M
OraSure Technologies, with a market cap of US$207.20 million, is navigating the challenges typical for penny stocks. Despite being unprofitable, it has managed to reduce losses over the past five years and maintains a strong balance sheet with short-term assets of US$313.8 million exceeding both short-term and long-term liabilities. Recent developments include a collaboration with Targeted Genomics to expand consumer access to at-home celiac genetic testing and filing shelf registrations potentially raising up to US$315.78 million, which could provide financial flexibility but may also lead to shareholder dilution if executed fully.
- Navigate through the intricacies of OraSure Technologies with our comprehensive balance sheet health report here.
- Evaluate OraSure Technologies' prospects by accessing our earnings growth report.
Dingdong (Cayman) (NYSE:DDL)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Dingdong (Cayman) Limited operates as an e-commerce company in China, with a market cap of approximately $417.89 million.
Operations: There are no reported revenue segments for Dingdong (Cayman) Limited.
Market Cap: $417.89M
Dingdong (Cayman) Limited, with a market cap of approximately US$417.89 million, has recently reported revenue growth, reaching CNY 5,479.04 million for Q1 2025 compared to the previous year. The company has become profitable over the past year and its operating cash flow covers debt well. Despite trading significantly below estimated fair value and having more cash than total debt, high Return on Equity is skewed by substantial debt levels. The management team and board are experienced, and the company announced a share repurchase program up to US$20 million funded from existing cash reserves until March 2026.
- Unlock comprehensive insights into our analysis of Dingdong (Cayman) stock in this financial health report.
- Examine Dingdong (Cayman)'s earnings growth report to understand how analysts expect it to perform.
Nerdy (NYSE:NRDY)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Nerdy, Inc. operates a platform for live online learning in the United States and has a market cap of approximately $307.55 million.
Operations: The company's revenue is primarily generated from its tutoring segment, amounting to $184.10 million.
Market Cap: $307.55M
Nerdy, Inc., with a market cap of US$307.55 million, recently reported first-quarter 2025 sales of US$47.6 million, down from US$53.73 million the previous year, alongside a net loss increase to US$10.5 million. Despite being unprofitable and experiencing increased losses over five years, Nerdy has no debt and sufficient cash runway for more than a year based on current free cash flow trends. The company raised its full-year revenue guidance to between US$191.5 million and US$200 million due to first-quarter performance but faces challenges with significant insider selling in recent months.
- Click here to discover the nuances of Nerdy with our detailed analytical financial health report.
- Learn about Nerdy's future growth trajectory here.
Key Takeaways
- Unlock more gems! Our US Penny Stocks screener has unearthed 727 more companies for you to explore.Click here to unveil our expertly curated list of 730 US Penny Stocks.
- Ready To Venture Into Other Investment Styles? These 19 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:OSUR
OraSure Technologies
Develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally.
Flawless balance sheet and slightly overvalued.
Similar Companies
Market Insights
Weekly Picks

An Undervalued 3.3Moz Gold Project in Canada
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire

The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.
Recently Updated Narratives
Worth Considering
Bajaj Auto has seen a correction in its stock price after a strong rally, making it an attractive opportunity for investors.

Aussie’s Barton Gold, No Debt Miner with 1 Mill That Changes Everything
Popular Narratives
NVIDIA will see a profit margin surge of 55% in the next 5 years
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

